Tchydroxyethylene diphosphonate showed uptake in several soft tissues as well as the heart ( Figure 2) . 1 Echocardiography at that time still showed normal left ventricular end-diastolic volume (74 mL/m 2 ), normal left ventricular function (ejection fraction, 56%; global longitudinal systolic strain, 17.4%), normal wall thickness (interventricular septum, 10 mm; posterior wall, 10 mm; and right ventricular wall, 5 mm), normal diastolic function (septal e′ 10. Amyloidosis is a progressive systemic disease affecting a variety of tissues and organs, including the heart. In a subset of patients, the disease is hereditary because of a mutation in TTR, the gene encoding transthyretin, a transport protein of thyroxin and retinol-binding protein. 2 In the case of advanced disease, liver transplantation is a treatment option to remove the source of the abnormal transthyretin. The explanted liver is often used for patients with liver insufficiency (domino transplantation). 3 Amyloidosis after receiving a liver allograft donated by a patient with ATTR amyloidosis is an established, albeit relatively uncommon phenomenon. 3 However, even if it does occur, it usually takes many years for overt amyloidosis to develop in the recipient, reflecting the slow development of amyloidosis in donor patients with a TTR mutation, which legitimizes the use of these livers for transplantation. Moreover, the ensuing amyloidosis is usually confined to neuropathy. In fact, we are aware of only a single report of amyloidotic cardiomyopathy, which was demonstrated at autopsy. 4 The present case is remarkable for several reasons. First, it shows that amyloidosis may occur as early as 5 years after transplantation. Second, this is the first report of cardiac amyloidosis diagnosed ante mortem after receiving an ATTR liver. Finally, it shows that bone scintigraphy allows early diagnosis of cardiac involvement in patients with transthyretin-derived amyloidosis, even before conventional echocardiography.
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